A neonatal case of cutaneous blastic plasmacytoid dendritic cell neoplasm with transient regression
Yuan Fang
Department of Pathology, Anhui Provincial Children's Hospital, Hefei, China
Search for more papers by this authorYi-Zhen Wang
Department of Pathology, Anhui Provincial Children's Hospital, Hefei, China
Search for more papers by this authorCorresponding Author
Lian Chen
Department of Pathology, Children's Hospital of Fudan University, Shanghai, China
Correspondence
Lian Chen, Department of Pathology, Children's Hospital of Fudan University, 399 Wanyuan Rd, Shanghai 201102, China.
Email: [email protected]
Search for more papers by this authorYuan Fang
Department of Pathology, Anhui Provincial Children's Hospital, Hefei, China
Search for more papers by this authorYi-Zhen Wang
Department of Pathology, Anhui Provincial Children's Hospital, Hefei, China
Search for more papers by this authorCorresponding Author
Lian Chen
Department of Pathology, Children's Hospital of Fudan University, Shanghai, China
Correspondence
Lian Chen, Department of Pathology, Children's Hospital of Fudan University, 399 Wanyuan Rd, Shanghai 201102, China.
Email: [email protected]
Search for more papers by this author
REFERENCES
- 1Li Y, Sun V, Sun W, et al. Blastic plasmacytoid dendritic cell neoplasm in children. Hematol Oncol Clin North Am. 2020; 34(3): 601-612.
- 2Tokuda K, Eguchi-Ishimae M, Yagi C, et al. CLTC-ALK fusion as a primary event in congenital blastic plasmacytoid dendritic cell neoplasm. Genes Chromosomes Cancer. 2014; 53(1): 78-89.
- 3Li J, Wang J, Rong L, et al. A neonatal case of congenital blastic plasmacytoid dendritic cell neoplasm with KMT2C gene duplication. Ann Hematol. 2023; 102(1): 227-229.
- 4Blohm ME, Vesterling-Hörner D, Calaminus G, et al. Alpha 1-fetoprotein (AFP) reference values in infants up to 2 years of age. Pediatr Hematol Oncol. 1998; 15(2): 135-142.
- 5Taylor J, Haddadin M, Upadhyay VA, et al. Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark. Blood. 2019; 134(8): 678-687.
- 6Laribi K, Baugier de Materre A, Sobh M, et al. Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients. Blood Adv. 2020; 4(19): 4838-4848.
- 7Pagano L, Valentini CG, Pulsoni A, et al. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica. 2013; 98(2): 239-246.
- 8Pemmaraju N, Lane AA, Sweet KL, et al. Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm. N Engl J Med. 2019; 380(17): 1628-1637.
- 9 WHO Classification of Tumours Editorial Board. Haematolymphoid tumours. International Agency for Research on Cancer; 2024.
- 10Beird HC, Khan M, Wang F, et al. Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN). Blood Cancer J. 2019; 9(12): 99.
- 11Yin CC, Pemmaraju N, You MJ, et al. Integrated clinical genotype-phenotype characteristics of blastic plasmacytoid dendritic cell neoplasm. Cancers (Basel). 2021; 13(23): 5888.
